VOYA Investment Management
VYNE icon

VOYA Investment Management’s VYNE Therapeutics VYNE Stock Holding History

VOYA Investment Management’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18
Closed -$110K – 2907
2021
Q1 		$110K Hold
18
– – ﹤0.01% 2657
2020
Q4 		$105K Buy
18
+5
+38% +$31.4K ﹤0.01% 2551
2020
Q3 		$79K Buy
13
+3
+30% +$17.5K ﹤0.01% 2379
2020
Q2 		$64K Buy
10
+4
+67% +$27.1K ﹤0.01% 2413
2020
Q1 		$61K Buy
+6
New +$94.1K ﹤0.01% 2457

Other funds holding VYNE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

VOYA Investment Management's VYNE Position: Q2 2021 in Review

VOYA Investment Management sold out of VYNE Therapeutics (VYNE) in Q2 2021, closing a stake of 18 shares — an estimated $110K sold.

VOYA Investment Management first reported a position in VYNE in Q1 2020 and held it in 5 quarters. The position peaked at $110K in Q1 2021. 63 funds tracked by Wall St. Rank hold VYNE as of Q2 2021.

  • VOYA Investment Management reported no remaining VYNE Therapeutics position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 18 VYNE Therapeutics shares in Q2 2021, an estimated $110K.
  • VOYA Investment Management first reported a position in VYNE Therapeutics in Q1 2020 and held it in 5 quarters.
  • VOYA Investment Management's VYNE Therapeutics position peaked at $110K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.